Provided by Tiger Trade Technology Pte. Ltd.

Sensei Biotherapeutics, Inc.

13.85
0.0000
Volume:- -
Turnover:- -
Market Cap:18.56M
PE:-0.10
High:13.85
Open:13.85
Low:13.85
Close:13.85
52wk High:36.76
52wk Low:7.45
Shares:1.34M
Float Shares:810.90K
Volume Ratio:2.41
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-142.7282
EPS(LYR):-16.7239
ROE:-195.26%
ROA:-20.79%
PB:0.11
PE(LYR):-0.83

Loading ...

Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Jun 15, 2026

Major Issues Report

Form 8-K - Current report
Jun 10, 2026

Major Issues Report

Form 8-K - Current report
Jun 03, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 02, 2026

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
May 22, 2026

Major Issues Report

Form 8-K - Current report
May 21, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 15, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 15, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2026

Major Issues Report

Form 8-K - Current report
Apr 29, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 16, 2026

Major Issues Report

Form 8-K - Current report
Apr 15, 2026

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 31, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2026

Major Issues Report

Form 8-K - Current report
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities